Forma Therapeutics Holdings, Inc. (FMTX) Financial Statements (2023 and earlier)

Company Profile

Business Address 300 NORTH BEACON STREET
WATERTOWN, MA 02472
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments464,226633,054
Cash and cash equivalents77,421282,689
Short-term investments386,805350,365
Receivables11,98815,273
Prepaid expense3,5494,793
Other current assets 1,327
Other undisclosed current assets6,638 
Total current assets:486,401654,447
Noncurrent Assets
Operating lease, right-of-use asset22,074 
Property, plant and equipment13,9271,520
Long-term investments and receivables26,04712,534
Long-term investments26,04712,534
Other noncurrent assets12,61212,470
Total noncurrent assets:74,66026,524
TOTAL ASSETS:561,061680,971
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities29,96331,700
Taxes payable70301
Accounts payable4,1454,295
Accrued liabilities25,74827,104
Other undisclosed current liabilities5,125 
Total current liabilities:35,08831,700
Noncurrent Liabilities
Long-term debt and lease obligation:27,617 
Liabilities, other than long-term debt 1,027
Deferred rent credit 1,027
Operating lease, liability27,617 
Other undisclosed noncurrent liabilities(27,617) 
Total noncurrent liabilities:27,6171,027
Total liabilities:62,70532,727
Equity
Equity, attributable to parent, including:498,356648,244
Common stock47 
Additional paid in capital728,683705,607
Accumulated deficit(230,374)(57,410)
Other undisclosed equity, attributable to parent 47
Total equity:498,356648,244
TOTAL LIABILITIES AND EQUITY:561,061680,971

Income Statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
Operating expenses(173,986)(124,212)
Operating loss:(173,986)(124,212)
Nonoperating income1,17624,079
Investment income, nonoperating1,176767
Loss from continuing operations before income taxes:(172,810)(100,133)
Income tax expense (benefit)(154)29,719
Loss from continuing operations:(172,964)(70,414)
Loss before gain (loss) on sale of properties:(172,964)(70,414)
Net loss attributable to parent:(172,964)(70,414)
Other undisclosed net loss available to common stockholders, basic (3,736)
Net loss available to common stockholders, diluted:(172,964)(74,150)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
Net loss:(172,964)(70,414)
Comprehensive loss, net of tax, attributable to parent:(172,964)(70,414)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: